Verve Therapeutics
About Us
Why Cardiovascular Disease
Our Approach
Our Pipeline
Culture & Careers
Investors
Overview
News & Events
Stock Information
Corporate Governance
Financials & Filings
IR Resources
A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys
Post navigation
Previous Post
Previous
Big Tech Zeros In on the Virus-Testing Market
Next Post
Next
In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
Home
About Us
Why Cardiovascular Disease
Our Approach
Our Pipeline
Culture & Careers
Investors
►
◄ Back
Overview
News & Events
Stock Information
Corporate Governance
Financials & Filings
IR Resources
Contact Us